Professional Documents
Culture Documents
Author's Accepted Manuscript: Telfairia Occidentalis
Author's Accepted Manuscript: Telfairia Occidentalis
Author's Accepted Manuscript: Telfairia Occidentalis
PII: S0378-8741(17)32146-3
DOI: https://doi.org/10.1016/j.jep.2018.01.018
Reference: JEP11194
To appear in: Journal of Ethnopharmacology
Received date: 3 June 2017
Revised date: 27 December 2017
Accepted date: 14 January 2018
Cite this article as: Toyin Mohammed Salman, Isiaka Abdullateef Alagbonsi,
Abdul-Rahuf Aderemi Feyitimi and Peter O Ajayi, Telfairia occidentalis
Hook.f.-associated haematopoietic effect is mediated by cytokines but
independent of testosterone: a preliminary report, Journal of
Ethnopharmacology, https://doi.org/10.1016/j.jep.2018.01.018
This is a PDF file of an unedited manuscript that has been accepted for
publication. As a service to our customers we are providing this early version of
the manuscript. The manuscript will undergo copyediting, typesetting, and
review of the resulting galley proof before it is published in its final citable form.
Please note that during the production process errors may be discovered which
could affect the content, and all legal disclaimers that apply to the journal pertain.
Telfairia occidentalis Hook.f.-associated haematopoietic effect is mediated by cytokines but
Peter O Ajayia
a
Department of Physiology, College of Health Sciences, University of Ilorin, Ilorin, Kwara,
Nigeria.
b
Department of Physiology, Faculty of Medicine and Health Sciences, University of Gitwe,
Sciences, University of Gitwe, Gitwe, P.O. Box 1 Nyanza, Ruhango District, Southern Province,
Abstract
Ethnopharmacological relevance:
Telfairia occidentalis Hook.f. (TO) is popular in Nigeria for the ethnopharmacological use of its
leaves to improve haematological parameters in normal and anaemic subjects. Cytokines are
Twenty five (25) male rats were randomly divided into 3 oral treatment groups as follows: Group
1 (control, n=5) received 0.2 ml/kg normal saline for 14 days. Groups 2 and 3 (n= 10 each) were
subdivided into 2 (n=5) and received 100 mg/kg and 200 mg/kg of aqueous extract of TO
1
Results:
insignificant (p>0.05) in the first week but significant (p<0.05) in the second week (except for
lymphocyte and platelets count). Moreover, TO significantly reduced the testosterone but
Conclusion:
Graphical abstract
1.0. Introduction
blood elements occurs from a primitive pluripotent stem cells in an ordered sequence of
2
maturation and proliferation. Its regulation occurs at various levels that include but not limited to
the structure (stroma and cell-cell interactions), hormones and cytokines (e.g. erythropoietin,
health has been on an increase in Africa, especially Nigeria. Telfairia occidentalis Hook.f. (TO)
(Oliver, 1871) is one of such plants often consumed as leafy vegetable on daily basis in many
homes due to its traditionally perceived haematinic property (Eseyin et al., 2014; Salman et al.,
2008). Many researchers have documented that the plant possesses anti-oxidant (Nwanna and
Oboh, 2007), anti-diabetic (Eseyin et al., 2010; Nwozo et al., 2004), hepatoprotective (Oboh,
2005), anti-plasmodial (Okokon et al., 2009), anti-microbial (Oyewole and Abalaka, 2012),
testiculoprotective (Akang et al., 2011; Ejike and Ezeanyika, 2013; Salman et al., 2008),
testiculotoxic (Adisa et al., 2014; Saalu et al., 2010), anti-inflammatory (Oluwole et al., 2005) as
The traditionally-reported haematinic property of the leaf has been well-validated in the
scientific literatures. For instance, its aqueous extract has been shown to increase haematocrit
and reticulocyte count in rats (Lawal et al., 2015; Salman et al., 2008). Its
dependent increase in haematological indices such as red blood cell (RBC) and white blood cell
(WBC) counts, as well as haematocrit and haemoglobin concentrations (Alada, 2000; Odede et
al., 2010). Its potential to inhibit and reverse the sickling feature of sickled red blood cell has
also been reported (Cyril- Olutayo et al., 2012). Although the high iron content of its leaf has
been implicated as a possible reason for its traditional use as blood tonic, there appears to be
3
other under-explored mechanisms which might be responsible for its reported haematinic
property.
Interleukin-3 (IL-3), a growth factor majorly produced by thymus (T) cells and natural
killer (NK) cells, has been known to act predominantly by inducing the proliferation and
This study aimed at investigating the role of IL-3 and erythropoietin in TO-associated
haematopoietic effect.
Fresh leaves of Telfairia occidentalis Hook.f. (TO) were purchased from a farmer in
Yoruba road, Ilorin, Kwara state, Nigeria and authenticated by Mr. Bolu Ajayi in the Department
of Plant Biology, University of Ilorin, Ilorin, Nigeria. Its voucher number (UILH/001/959) was
deposited in the Herbarium. The leaves were air dried and reduced to powdery form by grinding.
One hundred and thirty-six grams (136 g) of its powder was soaked in 2 litres of distilled water
for 72 hours, after which it was sieved with a white cloth. The filtrate was then evaporated in
water bath at 40°C in order to obtain solid dried extract which was then dissolved in normal
Twenty-five (25) males Wistar albino rats weighing between 120-150g were obtained
from the Animal House of the Department of Biochemistry, Faculty of Life Sciences, University
4
of Ilorin, Kwara State, Nigeria, housed at room temperature with free access to food and water
ad libitum, and were maintained on the daily light/dark cycle. “Principles of laboratory animal
care (NIH publication No. 85-23, revised 1985)” were followed. All experiments have been
Twenty-five (25) male rats were randomly divided into 3 oral treatment groups as
follows:
-Group 1 (n=5) was the control and received 0.2 ml/kg normal saline for 14 days.
-Group 2a animals (n=5) received 100 mg/kg of TO while group 2b animals (n=5) received 200
-Group 3a animals (n=5) received 100 mg/kg of TO while group 3b animals (n=5) received 200
The doses and durations of treatment used in this study have been previously reported by
us (Salman et al., 2013). A day after the last treatment, the rats were sacrificed by administering
0.2 ml/kg body weight of ketamine hydrochloride. Blood samples were then collected via retro-
orbital and cardiac puncture into heparinised bottles and centrifuged at 3000 rpm for10 minutes.
Plasma was collected into plain bottles and refrigerated at 4oC prior to testosterone, IL-3 and
erythropoietin analyses. Another blood sample collected in EDTA bottle was analysed
The haematological indices including red blood cell count, haemoglobin concentration,
packed cell volume, total white blood cells, differential white blood cells count for lymphocytes
5
and neutrophils as well as platelets count were determined using the automated analyser
Sunnyvale, CA, USA) using enzyme-linked immunosorbent assay (ELISA) [Calbiotech, Spring
Valley, California, USA; product code: TE-1875], following kit manufacturer’s procedure.
microplate spectrophotometer; Molecular Device Co., Sunnyvale, CA, USA) using the rat IL-3
ELISA kit (Elabscience Biotechnology Co., Ltd, Wuhan, China; product code: E-EL-RO556)
Plus microplate spectrophotometer; Molecular Device Co., Sunnyvale, CA, USA) using
commercial ELISA kits (Elabscience Biotechnology Co., Ltd., Wuhan, China; product code: E-
Data were analysed using SPSS for windows (version 16.0). All values were expressed as
by Least Significance Difference (LSD) post-hoc test for multiple comparisons. p-Values of 0.05
6
3.0. Results
Treatment with both 100 mg/kg (7.04 ± 0.25 106/µl) and 200 mg/kg (7.48 ± 0.20 106/µl) of TO
caused no significant change (p>0.05) in the RBC count of rats at 7 days but significantly
increased it (p<0.05) at 14 days (7.61 ± 0.32 106/µl; 8.48 ± 0.25 106/µl respectively) when
Except for those that received 100 mg/kg of TO for 7 days (11.88 ± 0.86 g/dl), rats that
received its 100 mg/kg for 14 days (12.92 ± 0.49 g/dl) and those that received its 200 mg/kg for
7 days (12.90 ± 0.51 g/dl) and 14 days (14.54 ± 0.29 g/dl) had higher haemoglobin
Furthermore, there were apparent increases in the PCV of TO-treated rats that was
significant (p<0.05) only in those that received its 200 mg/kg for 14 days (44.93 ± 0.59 g/dl)
The pattern of WBC is similar to that of the RBC. Treatment with both 100 mg/kg (8.48
± 0.19 103/μl) and 200 mg/kg (7.86 ± 0.41 103/μl) of TO caused no significant change (p>0.05)
in the RBC count of rats at 7 days but significantly increased it (p<0.05) at 14 days (15.03 ± 1.37
103/μl; 13.53 ± 0.93 103/μl respectively) by 80.43 % and 62.42 % respectively when compared to
Administration of TO to rats did not significantly affect the lymphocytes counts (Table
1).
7
Furthermore, there were higher neutrophil counts in rats that received 100 mg/kg of TO
for 7 days (50.40 ± 3.32 %) and its 200 mg/kg for 14 days (43.78 ± 3.28 %) when compared to
1).
There were significant reductions (p<0.05) in the plasma testosterone of rats that received
100 mg/kg and 200 mg/kg of TO for 7 days (30.00 ± 4.47 ng/ml; 55.00 ± 3.87 ng/ml
respectively) and 14 days (43.80 ± 8.57 ng/ml; 12.50 ± 1.44 ng/ml respectively) when compared
The increase in IL-3 concentration was only significant (p<0.05) in rats that received 100
mg/kg of TO for 7 days (0.63 ± 0.09 pg/ml) but not significant (p>0.05) in others (0.41 ± 0.18
pg/ml), while there was an apparent insignificant decrease (p>0.05) in those that received 200
mg/kg of TO for 14 days (0.06 ± 0.01 pg/ml) when compared to control (0.23 ± 0.04 pg/ml)
(Figure 2).
The pattern of erythropoietin is also similar to that of RBC. Treatment with both 100
mg/kg (1800.00 ± 100.00 mIU/ml) and 200 mg/kg (2266.70 ± 66.67 mIU/ml) of TO caused no
significant change (p>0.05) in the EPO concentration of rats at 7 days but significantly increased
it (p<0.05) at 14 days (2908.30 ± 200.17 mIU/ml; 2887.50 ± 162.46 mIU/ml respectively) when
8
4.0. Discussion
parameters in normal (Alada, 2000; Ifeanyi et al., 2014; Salman et al., 2008) and anaemic rats
(Toma et al.., 2015). The present study also supports the traditional and scientific claims that TO
has haematopoietic effect and additionally shows that this effect could be mediated by cytokines
Interleukin-3, primarily derived from activated CD4+ T-cells and mast cells, is a multi-
macrophages, dentritic cells, and megakaryocytes from the bone marrow in vitro (Broughton et
al., 2012) and in vivo (Ihle, 1992). In addition to promoting mast cell growth, differentiation and
mediator release (Gurish and Boyce, 2002; Hu et al., 2007), it also promotes basophil
development and stimulates IL-4, IL-6, and histamine release (Karasuyama et al., 2011; Lantz et
al., 2008; Voehringer, 2012) during allergic inflammation. Moreover, it promotes eosinophilic
(Khwaja et al., 1994), modulates development of regulatory T cells (Srivastava et al., 2011), and
stimulates endothelial cells proliferation and migration (Dentelli et al., 1999). The present study
suggests that the TO-associated increase in IL-3 levels, possibly by increasing lymphocytes
concentration, might have contributed to its erythropoietic and leucopoietic effects. This is in
agreement with the previously reported improvement in CD4+, a marker of helper T-cells status
9
The hormone erythropoietin, produced mainly in the kidney and liver in response to
oxygen tension, is required for the maintenance of a steady supply of red blood cells by
enhancing the proliferation and differentiation of erythrocytic progenitor cells in the bone
marrow. Hypoxia is known to be the main factor that induces erythropoietin mRNA expression
and protein secretion in the kidney and liver cells (Haase, 2013). Moreover, testosterone and its
in a hypoxia-dependent manner, though 5α-DHT is more potent than testosterone (Paulo et al.,
1974). For instance, pre-treatment of isolated perfused canine kidneys with testosterone
testosterone to the perfusate of normal canine kidney did not (Malgor and Fisher, 1970).
while long-term oxygen therapy in male patients with respiratory failure increases plasma
observed in this study was unexpected. Our data suggest that the TO-associated constitutive
increase in erythropoietin secretion is not dependent on testosterone secretion, a claim that could
be explained from two perspectives. First, we rather speculate that the elevated red blood cells
secretion, in addition to the abundant iron present in TO, could have favoured high rate of
oxygen transport to the tissues and resulted in plasma ‘oxygen debt’. This resulting hypoxaemia
might have contributed to reduction in plasma testosterone and supports the contention that
hypoxia attenuates plasma testosterone levels (Semple et al., 1980; Wang et al., 1996). Second,
TO and certain fatty acids, including palmitic, stearic, myristic, oleic, linolenic and linoleic
10
acids, whose abundant presence in TO has been observed by us (unpublished data) and reported
by others (Esuoso et al., 1998), have been shown to possess inhibitory activity on 5 α-reductase
activity, thereby decreasing the formation of 5 α-DHT from testosterone (Abe et al., 2009;
Gossell-Willaims et al., 2006; Liu et al., 2009) and are therefore of therapeutic importance in the
management of acne, male pattern alopecia and benign prostatic hyperplasia (Cho et al., 2014;
Ejike and Ezeanyika, 2011). Though the present study is limited by non-availability of data on 5
α-reductase and 5α-DHT, it is however tempting to opine that the reduction in testosterone
following TO administration in this study might not be secondary to its conversion to 5α-DHT,
and that the TO-associated increase in erythropoietin is not dependent on androgen. This is in
agreement with previous observation that testosterone and erythropoietin do not depend on each
well-reported (Brines et al., 2000; Lifshitz et al., 2010; Siren et al., 2001). A decreased bone
marrow erythropoiesis and aggravated anaemia have been observed during Trypanosoma brucei
erythropoietin has been used to prevent death of mice during Plasmodium berghei infection due
to its ability to ameliorate parasite-induced anaemia, decrease neuronal apoptosis, and reduce
TNF-α and interferon-γ production (Kaiser et al., 2006). However, exacerbated macrophages
activation and its associated excessive inflammation in erythropoietin-pre-treated mice have been
reported to increase mortality in Salmonella typhimurium (Nairz et al., 2011) and Histoplasma
capsulatum (Locachevic et al., 2015) infection. These suggest that macrophages (non-erythroid
11
It is interesting to know that some important components of TO have haematological
from our laboratory (unpublished data) and others (Esuoso et al., 1998) show that it has
appreciable amount of saturated (myristic, palmitic and stearic acids), monounsaturated (oleic
acid) and polyunsaturated (linoleic and α-linolenic acid) long chain fatty acids (FAs). TO has
also been known to be a rich source of iron (Esuoso et al., 1998), a widely known
haematopoietic metal that binds with plasma apotransferrin and forms iron-ferritin complex
which further binds with erythroblast’s receptors and activates reticuloendothelial cells in the
bone marrow. While the haeme component of the haemoglobin is synthesised in these cells, the
globin chains can also be formed by amino acids in TO (Ekpenyong et al., 2012). Moreover,
lymphocytes are enhanced by linoleic acid (Sierra et al., 2005) but depressed by oleic acid
(Llado et al., 2010; Verlengia et al., 2003). Palmitic acid increases the production of pro-
inflammatory cytokines (interleukins 1, 6 and 8 and TNF-α) (Joshi-Barve et al., 2007; Shirasuna
et al., 2016; Zhou et al., 2013) , which may lead to neutrophil infilteration and inflammation in
the hepatocyte. Contrarily, the anti-inflammatory activities of α-linolenic and linoleic acids by
decreasing interleukin 6 and increasing interleukin-1receptor antagonist have been reported (Lee
et al., 2009; Rallidis et al., 2003). It is hypothesised that the iron and fatty acids present in TO
might account for its haematopoietic action. It is also noteworthy that the possibility of
synergistic relationship between IL-3 and erythropoietin in the haematopoietic effect caused by
TO cannot be ruled out. For instance, their cooperation in the expansion of late erythropoiesis
has been previously observed in vivo as reticulocytes and late erythroid progenitors levels were
higher in primates given IL-3 and erythropoietin than in those given the later alone (Umemura et
al., 1989).
12
The present study has some limitations. First, that metabolites of testosterone were not
measured could not avail us data to know what was actually responsible for the reduction in its
concentration. Second, how cytokines production was elicited by TO was not further
investigated. Third, it was not determined if TO could as well enhance the cytokines in anaemic
rats. The limitations are however offset by an important strength that this preliminary study is the
Conflict of interest
None declared
Funding
None
Authors contributions
TMS and AAF conceived the study. AAF carried out the study. IAA and AOP analysed the data.
References
Abe, M., Ito, Y., Oyunzul, L., Oki-Fujino, T., Yamada, S., 2009. Pharmacologically relevant
receptor binding characteristics and 5α-reductase inhibitory activity of free fatty acids contained
Adisa, W.A., Okhiai, O., Bankole, J.K., Iyamu, O.A., Aigbe, O., 2014. Testicular damage in
Telfairia Occidentalis extract-treated Wistar rats. Am. J. Med. Biol. Res. 2, 37-45.
13
Akang, E., Oremosu, A., Dosumu, O., Ejiwunmi, A., 2011. Telfairia occidentalis, a prophylactic
medicine for alcohol's damaging effect on the testis. Macedon J. Med. Sci. 4, 380-387.
Alada, A., 2000. The haematological effect of Telferia occidentalis diet preparation. Afr. J.
Brines, M.L., Ghezzi, P., Keenan, S., Agnello, D., de Lanerolle, N.C., Cerami, C., et al., 2000.
Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc.
Broughton, S.E., Dhagat, U., Hercus, T.R., Nero, T.L., Grimbaldeston, M.A., Bonder, C.S., et
al., 2012. The GM-CSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation
Cho, Y.H., Lee, S.Y., Jeong, D.W., Choi, E.J., Kim, Y.J., Lee, J.G., et al., 2014. Effect of
pumpkin seed oil on hair growth in men with androgenetic alopecia: a randomised, double-blind,
placebo-controlled trial. Evidence-based Compl. Altern. Med. Volume 2014, Article ID 549721,
7 pages
Cyril-Olutayo, C., Agbedahunsi, J., Elufioye, O., 2012. Anti-sickling properties of some
indigenous and exotic plant species in Nigeria. Planta Med. 78, I2-17.
Dacie, J.V., Lewis, S.M., 2001. Practical haematology. Eleventh ed. Longman Group.Ltd., Hong
Kong. pp 11-17.
Delev, D., Rangelov, A., Ubenova, D., Kostadinov, I., Zlatanova, H., Kostadinova, I., 2016.
1489-1492.
14
Dentelli, P., Sorbo, L.D., Rosso, A., Molinar, A., Garbarino, G., Camussi, G., et al., 1999.
Human IL-3 stimulates endothelial cell motility and promotes in vivo new vessel formation. J.
Egba, S.I., Njoku, O.U., Anaduaka, E.G., Okibe, C.O., 2014. Stimulation of haemopoiesis and
Ejike, C., Ezeanyika, L., 2013. A Telfairia occidentalis seed-incorporated diet may be useful in
inhibiting the induction of experimental andropause. Ann. Med. Health Sci. Res. 2, 41-45.
Ejike, C.E.E.C., Ezeanyika, L.U.S., 2011. Inhibition of the experimental induction of benign
prostatic hyperplasia: a possible role for fluted pumpkin (Telfairia occidentalis Hook f.) seeds.
Ekpenyong, C.E., Okon, U.A., Samson, T.K., Akpan, E.E., 2012. Bioactive constituents, acute
and sub-acute effect of Telfairia occidentalis Hook F (fluted pumpkin) leaves extract on some
Eseyin, O., Ebong, P., Eyong, E., Awofisayo, O., Agboke, A., 2010. Effect of Telfairia
Eseyin, O.A., Sattar, M.A., Rathore, H.A., Ahmad, A., Afzal, S., Lazhari, M., et al., 2014.
Esuoso, K., Lutz, H., Kutubuddin, M., Bayer, E., 1998. Chemical composition and potential of
some underutilised tropical biomass. I: fluted pumpkin (Telfairia occidentalis). Food Chem. 61,
487-492.
15
Gossell-Willaims, M., Davis, A., O’Connor, N., 2006. Inhibition of testosterone-induced
hyperplasia of the prostate of Sprague-Dawley rats by pumpkin seed oil. J. Med. Food. 9, 284-
286.
Gurish, M., Boyce, J., 2002. Mast cell growth, differentiation, and death. Clin. Rev. Allergy
Haase, V.H., 2013. Regulation of erythropoiesis by hypoxia-inducible factors. Blood Rev. 27,
41-53.
Hu, Z., Zhao, W., Shimamura, T., 2007. Regulation of mast cell development by inflammatory
Ifeanyi, O.E., Ifeoma, C., Ndubuisi, O.T., Nwakaego, O.B., Braxton, A.Q., 2014.
Haematological effects of fluted pumpkin (Telfairia occidentalis) leaves in rats. Int. J. Life Sci.
Ihle, J., 1992. Interleukin-3 and haematopoiesis. Chem. Immunol. 51, 65-106.
Joshi-Barve, S., Barve, S.S., Amancherla, K., Gobejishvili, L., Hill, D., Cave, M., et al., 2007.
Kaiser, K., Texier, A., Ferrandiz, J., Buguet, A., Meiller, A., Latour, C., et al., 2006.
Recombinant human erythropoietin prevents the death of mice during cerebral malaria. J. Infect.
Diseases. 7, 987-995.
Karasuyama, H., Mukai, K., Obata, K., Tsujimura, Y., Wada, T., 2011. Non-redundant roles of
Khwaja, A., Addison, I., Johnson, B., Yong, K., Linch, D., 1994. Interleukin-3 administration
16
Lantz, C., Min, B., Tsai, M., Chatterjea, D., Dranoff, G., Galli, S., 2008. IL-3 is required for
increases in blood basophils in nematode infection in mice and can enhance IgE-dependent IL-4
Lawal, B., Shittu, O.K., Rotimi, A.A., Olalekan, I.A., Kamooru, A.A., Ossai, P.C., 2015. Effect
Lee, Y., Thompson, J.T., Vandel Heuvel, J.P., 2009. 9E,11E-Conjugated linoleic acid increases
Lifshitz, L., Tabak, G., Gassmann, M., Mittelman, M., Neumann, D., 2010. Macrophages as
Liu, J., Shimizu, K., Kondo, R., 2009. Anti-androgenic activity of fatty acids. Chem. Biodivers.
6, 503-512.
Llado, V., Gutierrez, A., Martinez, J., Casas, J., Teres, S., Higuera, M., et al., 2010. Minerval
induces apoptosis in Jurkat and other cancer cells. J. Cell Mol. Med. 14, 659-670.
Locachevic, G.A., Pereira, P.A.T., Secatto, A., Fontanari, C., Galvao, A.F., Prado, M.K.B., et al.,
Maggio, M., Snyder, P.J., Ceda, G.P., Milaneschi, Y., Luci, M., Cattabiani, C., et al., 2013. Is the
17
Malgor, L.A., Fisher, J.W., 1970. Effects of testosterone on erythropoietin production in isolated
Nairz, M., Schroll, A., Moschen, A.R., Sonnweber, T., Theurl, M., Theurl, I., et al., 2011.
Nishimura, K., Nakaya, H., Nakagawa, H., Matsuo, S., Ohnishi, Y., Yamasaki, S., 2011. Effect
Nwanna, E.E., Oboh, G., 2007. Anti-oxidant and hepatoprotective properties of polyphenol
Nwozo, S.O., Adaramoye, O.A., Ajaiyeoba, E.O., 2004. Anti-diabetic and hypolipidemic studies
of Telfairia occidentalis on Alloxan-induced diabetic rats. Niger. J. Nat. Prod. Med. 8, 45-47.
Oboh, G., 2005. Hepatoprotective property of ethanolic and aqueous extracts of fluted pumpkin
Odede, T., Ikusagba, B., Odetola, A., 2010. Effect of Telfairia occidentalis on erythrocyte
indices of rats following acute blood loss. Afr. J. Med. Med. Sci. 239, 117.
Okokon, J.E., Ekpo, A.J., Eseyin, O.A., 2009. Evaluation of in vivo anti-malarial activities of
ethanolic leaf and seed extracts of Telfairia occidentalis. J. Med. Food. 12, 649-653.
Oliver, D., 1871. Flora of tropical Africa. Dyer, T. (ed.), London: 1868-1900.
Oluwole, E., Falode, A., Ogundipe, O., 2005. Anti-inflammatory effect of some common
Oyewole, O., Abalaka, M., 2012. Anti-microbial activities of Telfairia occidentalis (fluted
pumpkins) leaf extract against selected intestinal pathogens. J. Health Sci. 2, 1-4.
18
Paulo, L.G., Fink, G.D., Roh, B.L., Fisher, J.W., 1974. Effects of several androgen and steroid
metabolites on erythropoietin production in the isolated perfused dog kidney. Blood. 43, 39-47.
Rallidis, L.S., Paschos, G., Liakos, G.K., Velissaridou, A.H., Anastasiadis, G., Zampelas, A.,
2003. Dietary α-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6
Rothenberg, M., Owen, W., Silberstein, D., Woods, J., Soberman, R., Austen, K., et al., 1988.
Human eosinophils have prolonged survival, enhanced functional properties, and become
Saalu, L.C., Kpela, T., Benebo, A.S., Oyewopo, A.O., Anifowope, E.O., Oguntola, J.A., 2010.
Hook f. leaves extract in rat. Int. J. Appl. Res. Nat. Prod., 3, 27-38.
Salman, T. M., Olayaki, L. A., Oyeyemi, W. A., 2008. Aqueous extract of Telfairia occidentalis
leaves reduces blood sugar and increases haematological and reproductive indices in male rats.
Salman, T.M., Alagbonsi, I.A., Biliaminu, S.A., Ayandele, O.A., Oladejo, O.K., Adeosun, O.A.,
Semple, P.D., Beastall, G.H., Watson, W.S., Hume, R., 1980. Serum testosterone depression
Shirasuna, K., Takano, H., Seno, K., Ohtsu, A., Karasawa, T., Takahashi, M., et al., 2016.
Palmitic acid induced interleukin 1 β secretion via NLRP3 inflammasomes and inflammatory
responses through ROS production in human placental cells. J. Reprod. Immunol., 116, 104-
112.
19
Sierra, S., Lara-Villoslada, F., Olivares, M., Jimenez, J., Boza, J., Xaus, J., 2005. Increased
immune response in mice consuming rice bran oil. Eur. J. Nutr. 44, 509-516.
Siren, A.L., Fratelli, M., Brines, M., Goemans, C., Casagrande, S., Lewczuk, P., et al., 2001.
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc.
Smith, B.R., 1990. Regulation of Haematopoiesis. Yale J. Biol. Med. 63, 371-380
Srivastava, R.K., Tomar, G.B., Barhanpurkar, A.P., Gupta, N., Pote, S.T., Mishra, G.C., et al.,
Toma, I., Victory, N.C., Kabir, Y., 2015. The effect of aqueous leaf extract of fluted pumpkin on
Umemura, T., Al-Khatti, A., Donahue, R.E., Papayannoupoulou, Th., Stamatoyannopoulos, G.,
1989. Effects of interleukin-3 and erythropoietin on in vivo erythropoiesis and F-Cell formation
Verlengia, R., Gorjao, R., Kanunfre, C.C., Bordin, S., de Lima, T.M., Curi, R., 2003. Effect of
Jurkat cells – a comparison with oleic acid. Life Sci. 73, 2939-2951.
Voehringer, D., 2012. Basophil modulation by cytokine instruction. Eur. J. Immunol. 42, 2544-
2550.
Wang, R.Y., Tsai, S.C., Lu, C.C., Shih, H.C., Chen, Y.H., Tung, Y.F., et al., 1996. Effect of
aging on erythropoietin secretion in male rats. J. Gerontol.: Biol. Sci. 51A, B434-B438.
20
Zhou, B., Zhang, J., Zhang, Q., Permatasari, F., Xu, Y., Wu, D., et al., 2013. Palmitic acid
100
Testosterone (ng/ml)
80
60 *
*
40 *
20 *
0
Control 100 mg/kg TO 7d 200 mg/kg TO 7d 100 mg/kg TO 14d 200 mg/kg TO 14d
0.8
*
Interleukin-3 (pg/ml)
0.6
0.4
0.2
0.0
Control 100 mg/kg TO 7d 200 mg/kg TO 7d 100 mg/kg TO 14d 200 mg/kg TO 14d
21
Erythropoietin (mIU/ml) 4000
* *
3000
2000
1000
0
Control 100 mg/kg TO 7d 200 mg/kg TO 7d 100 mg/kg TO 14d 200 mg/kg TO 14d
22